Shanghai Shyndec Pharmaceutical Co., Ltd.

¥8.29As of Sun 8 Nov 2026, 12:00 UTC
SSE:600420Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (4.41%)
Div yield 3.62%
ROE 4.04%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.12
PE TTM 24.63
TSR TTM (18.19%)
Mkt cap ¥11.12B
ROIC 4.74%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥7.94
(4.22%)
(92.25%)
Hold 10|4|6|8|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.09
0.09
0.09
0.10
16.81%
2.12%
0.91%
12.60%
Revenue¥M
937.6
951.4
987.8
980.1
9.14%
6.33%
12.41%
5.90%
Peers (US$1.667B)
Cap (US$)
PE
1.629B
51.47x
1.622B
23.44x
1.686B
12.63x
Capital
TTM
5Y
10Y
Leveragex
1.545
0.071
0.066
EBIT/Intx
0.591
0.543
0.526
Own earn%
(245.27)
(153.25)
(133.06)
Sh yield%
47.27
24.64
23.50
Owners
Insiders/Inst%
9.20
76.80
Short interest%
2.53
SBC / revenue%
5.46
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
10–14
$1 testx
−0.1
Incr. ROIC%
0